Dorsal and ventral hippocampal cholinergic systems modulate anxiety in the plus-maze and shock-probe tests

被引:99
作者
Degroot, A [1 ]
Treit, D [1 ]
机构
[1] Univ Alberta, Dept Psychol, Edmonton, AB T6G 2E9, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
acetylcholine; fear; dorsal hippocampus; ventral hippocampus; plus-maze; shock-probe;
D O I
10.1016/S0006-8993(02)02965-7
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
There is emerging evidence that increased acetylcholine levels in brain reduce anxiety. More specifically there is evidence that some of these anxiolytic effects of acetylcholine are modulated by the hippocampus. In the present study we examined the roles of the cholinergic systems in the dorsal and ventral hippocampus in two animal models of anxiety: the elevated plus-maze and the shock-probe burying tests. We found that microinfusions (10 mug/0.5 mul) of the acetylcholinesterase inhibitor physostigmine in either the dorsal or the ventral hippocampus increased rats' open arm exploration in the plus-maze test, and decreased burying behavior in the shock-probe test. Interestingly, infusions in the ventral, but not the dorsal hippocampus also increased the number of contacts rats made with the shock-probe. Overall, the results suggest that cholinergic stimulation in the dorsal and ventral hippocampus modulate anxiety, but that only the ventral hippocampal cholinergic system is involved in the passive avoidance of painful stimuli. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:60 / 70
页数:11
相关论文
共 64 条
[1]  
Amaral David G., 1995, P443
[2]   The psychobiology of anxiolytic drugs - Part 2: pharmacological treatments of anxiety [J].
Argyropoulos, SV ;
Sandford, JJ ;
Nutt, DJ .
PHARMACOLOGY & THERAPEUTICS, 2000, 88 (03) :213-227
[3]   AUTORADIOGRAPHIC ANALYSIS OF DIFFERENTIAL ASCENDING PROJECTIONS OF DORSAL AND MEDIAN RAPHE NUCLEI IN RAT [J].
AZMITIA, EC ;
SEGAL, M .
JOURNAL OF COMPARATIVE NEUROLOGY, 1978, 179 (03) :641-667
[4]   Hippocampal cholinergic blockade enhances hypothalamic-pituitary-adrenal responses to stress [J].
Bhatnagar, S ;
Costall, B ;
Smythe, JW .
BRAIN RESEARCH, 1997, 766 (1-2) :244-248
[5]  
Bourin M, 2001, Curr Opin Investig Drugs, V2, P259
[6]   NICOTINIC RECEPTOR AGONISTS EXHIBIT ANXIOLYTIC-LIKE EFFECTS ON THE ELEVATED PLUS-MAZE TEST [J].
BRIONI, JD ;
ONEILL, AB ;
KIM, DJB ;
DECKER, MW .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 238 (01) :1-8
[7]   Neuropsychiatric aspects of Alzheimer's disease: The cholinergic hypothesis revisited [J].
Cummings, JL ;
Kaufer, D .
NEUROLOGY, 1996, 47 (04) :876-883
[8]   PLASMA-CATECHOLAMINE AND CORTICOSTERONE LEVELS DURING ACTIVE AND PASSIVE SHOCK-PROD AVOIDANCE-BEHAVIOR IN RATS - EFFECTS OF CHLORDIAZEPOXIDE [J].
DEBOER, SF ;
SLANGEN, JL ;
VANDERGUGTEN, J .
PHYSIOLOGY & BEHAVIOR, 1990, 47 (06) :1089-1098
[9]  
DECKER MW, 1994, J PHARMACOL EXP THER, V270, P319
[10]   Septal GABAergic and hippocampal cholinergic systems modulate anxiety in the plus-maze and shock-probe tests [J].
Degroot, A ;
Kashluba, S ;
Treit, D .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2001, 69 (3-4) :391-399